Acute coronary syndrome (ACS) is associated with both short-and long-term unfavorable prognosis. Therefore, medical societies developed risk scores for predicting mortality and assessing decision-making regarding early aggressive treatment in patients presenting an ACS. The Thrombolysis In Myocardial Infarction and the Global Registry of Acute Coronary Events risk scores are the most extensively investigated scores for ACS. Clinical judgment is also important. Significant differences in aggressive treatment of ACS still exist with respect to gender, age, and ethnicity. The reasons for these discrepancies need to be further elucidated in future studies. Therefore, generalizability of stratifications and risk scores in certain populations should be performed with caution.
Acute coronary syndrome (ACS) is associated with both shortand long-term unfavorable prognosis. Therefore, accurate prediction of mortality risk in patients presenting with an ACS is very important for decision-making regarding early aggressive treatment (mainly primary percutaneous coronary intervention [pPCI] ). Significant differences in aggressive treatment of ACS exist with respect to gender, age, and ethnicity. [1] [2] [3] In this context, studies evaluating pPCI in women with ACS suggested that women undergo pPCI less often than men. [4] [5] [6] [7] However, there are some conflicting results reporting similar or even higher rates of percutaneous coronary intervention (PCI) in women with ACS as those derived from the Coronary Angiography and PCI Registry of the German Society of Cardiology. 8 It should be noted that women with stroke are also less treated with intravenous thrombolysis than men 9 and that gender differences have been reported for both traditional and emerging cardiovascular risk factors [10] [11] [12] ; risk factors are less frequently and less aggressively treated in women than in men. 13 With regard to age, elderly patients with ACS may have atypical symptoms, severe comorbidities affecting drug metabolism and their functional status, and an increased risk for cardiovascular mortality. 14 These age-related characteristics may negatively influence their treatment strategy and outcomes. Older patients with ACS can benefit from (and therefore should not be deprived of) early coronary revascularization. 15, 16 Interestingly, a 35-year-old man, cigarette smoker without electrocardiogram abnormalities but with an elevated cardiac troponin (cTN) concentration may have a Global Registry of Acute Coronary Events (GRACE) score *80, whereas an elderly person with elevated cTn and nonspecific fixed electrocardiographic changes will have a GRACE score >140. These scores suggest treating the younger patient with medications and the older patient invasively. 17 According to the GRACE score, those classified at moderate and high mortality risk should receive more aggressive early therapy.
With regard to ethnicity, Hispanic and black patients with ACS are more likely to initiate treatment later and experience worse outcomes compared with white non-Hispanic patients. 18 A cohort study with New Zealand residents showed that Asian patients were more likely to undergo coronary revascularization than Indian, European/other, Maori, and Pacific patients following an ACS. 19 In the Gulf region, a previous study reported racial differences in baseline risk factors and GRACE score in patients with ACS. 20 In this context, Thalib et al 21 in this issue of Angiology validated the GRACE risk score postdischarge in 5113 patients with ACS from the Arabian Gulf and found good calibration and discrimination ability to categorize the patients by their mortality risk.
The GRACE and the Thrombolysis In Myocardial Infarction (TIMI) risk scores are the most extensively investigated scores for ACS. The TIMI risk score originally assessed the 30-day mortality of individuals with ST-segment elevation myocardial infarction 22 and was subsequently validated for those undergoing pPCI to predict 1-year mortality. 23 The GRACE score derived from a large registry of patients with ACS (n ¼ 102 341) to predict their risk of death; there are 2 GRACE scores, one to assess in-hospital mortality and another to predict death from discharge up to 6 months. [24] [25] [26] [27] The GRACE scores have been developed using age, heart rate, systolic blood pressure, creatinine, Killip classification of heart failure, ST-segment deviation, elevated cTn, and the occurrence of cardiac arrest on admission. [28] [29] [30] [31] [32] [33] Manzano-Fernández et al 34 compared the GRACE and the Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines risk scores to predict in-hospital mortality and major bleeding in 1587 consecutive patients with ACS and found that the GRACE risk score had a better predictive performance for assessing in-hospital mortality and major bleeding. Furthermore, both American and European guidelines 35, 36 recommend the use of the TIMI risk score for prognosis assessment and therapeutic decision-making in ACS. 37 Additional tools for coronary artery disease prognosis have been developed, including synergy between PCI with TAXUS (Paclitaxel-Eluting stents, Boston Scientific) and cardiac surgery SYNTAX (SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery) study, SYN-TAX score (SS), 38, 39 dynamic TIMI, the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC), the Primary Angioplasty in Myocardial Infarction (PAMI), and the Zwolle scores. 40 The dynamic TIMI risk model uses in-hospital events for reassessing the risk of patients discharged from hospital. 41 Both CADILLAC and PAMI risk scores were developed for patients treated by invasive procedures to predict 1-year and 6-month mortality, respectively. 42, 43 The Zwolle score predicts 30-day mortality, and it is used to identify patients at low risk who are suitable for an early discharge from hospital. 44 Littnerova et al 45 found that GRACE score was more predictive compared with the CADILLAC, PAMI, TIMI, dynamic TIMI, and Zwolle scores.
Acute coronary syndrome outcomes may be influenced by baseline risk factors. 46 In this context, Taşolar et al 47 incorporated the CHA2DS2-VASc-HS score as a predictor of ACS outcomes. The CHA2DS2-VASc-HS nomenclature represents congestive heart failure (C), hypertension (H), age 75 years (A2), diabetes mellitus (D), history of stroke or transient ischemic episode (S2), vascular disease (V), age 65 to 74 years (A), and male gender (as the sex category), hyperlipidemia (HL), and smoking (S). The authors compared the diagnostic accuracy of the CHA2DS2-VASc-HS score with the TIMI and GRACE risk scores to determine in-hospital major adverse cardiovascular events and found no differences. 47 Overall, TIMI and GRACE risk scores are the most extensively investigated scores for ACS, with GRACE performing better. 48 There are other potentially useful ACS risk scores available; however, these have not undergone rigorous validation. Clearly, clinical judgment is important and generalizability of the risk scores to patients of other nations should be performed with caution.
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